YTHDF2 drives oral squamous cell carcinoma progression via m6A-dependent degradation of MTUS1/ATIP1 mRNA and mitochondrial dysregulation
Cellular Signalling · 2025-12 · 136 · 112145
DOI: 10.1016/j.cellsig.2025.112145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025-12. Verfasst von Dongxiao Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510630, China. Hauptthemen laut MEDLINE: RNA Helicases, Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms, tRNA Methyltransferases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
N6-methyladenosine (m6A), the most abundant RNA modification, regulates mRNA stability through reader proteins such as YTHDF2. Here, we investigate YTHDF2's role in oral squamous cell carcinoma (OSCC) progression. Clinical analyses revealed elevated YTHDF2 expression in OSCC tumors compared to normal tissues, correlating with advanced disease stage, metastasis, and reduced patient survival. Mechanistically, OSCC exhibits global m6A hypomethylation, while YTHDF2 selectively destabilizes tumor-suppressive MTUS1/ATIP1 mRNA by recognizing m6A motifs in its 3' untranslated region. Functional studies using lentiviral overexpression and knockdown models demonstrated that YTHDF2 promotes tumor growth and mitochondrial dysfunction, whereas its suppression inhibits malignant behaviors and stabilizes MTUS1/ATIP1. Co-silencing MTUS1/ATIP1 reversed the anti-tumor effects of YTHDF2 depletion in vitro and in subcutaneous xenograft models. These findings establish YTHDF2 as a driver of OSCC progression through m6A-dependent suppression of MTUS1/ATIP1, linking mitochondrial dysregulation to tumorigenesis. Our study proposes therapeutic targeting of the YTHDF2-MTUS1/ATIP1 axis to improve OSCC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510630, China.
- Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China.
- Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China. Electronic address: heqt3@mail.sysu.edu.cn.
- Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510080, China. Electronic address: wanganx@mail.sysu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Tang, D., Cao, C., Huang, S., He, Q., & Wang, A. (2025). YTHDF2 drives oral squamous cell carcinoma progression via m6A-dependent degradation of MTUS1/ATIP1 mRNA and mitochondrial dysregulation. Cellular Signalling, 136, 112145. https://doi.org/10.1016/j.cellsig.2025.112145
Vancouver
Tang D, Cao C, Huang S, He Q, Wang A. YTHDF2 drives oral squamous cell carcinoma progression via m6A-dependent degradation of MTUS1/ATIP1 mRNA and mitochondrial dysregulation. Cellular Signalling. 2025;136:112145. doi:10.1016/j.cellsig.2025.112145
BibTeX
@article{Tang2025,
author = {Tang, Dongxiao and Cao, Congyuan and Huang, Shuojin and He, Qianting and Wang, Anxun},
title = {YTHDF2 drives oral squamous cell carcinoma progression via m6A-dependent degradation of MTUS1/ATIP1 mRNA and mitochondrial dysregulation},
journal = {Cellular Signalling},
year = {2025},
volume = {136},
pages = {112145},
doi = {10.1016/j.cellsig.2025.112145}
}
EUVIMED